Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Henrike Lenzen, Tobias J. Weismüller, Ahmed A. Negm, Jenny Wlecke, Stephanie Loges, Christian P. Strassburg, Michael P. Manns & Tim O. Lankisch. (2013) Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology 48:10, pages 1205-1212.
Read now
Read now
Gabriele I. Kirchner, Gabriele I. Kirchner, Jens J. W. Tischendorf, Jörg Bleck, Siegfried Wagner, Martin Caselitz, Juergen Klempnauer, Michael P. Manns & Michael Gebel. (2008) Perihilar lymph nodes in patients with primary sclerosing cholangitis with and without cholangiocellular carcinoma. Scandinavian Journal of Gastroenterology 43:11, pages 1366-1370.
Read now
Read now
J. J. W. Tischendorf, P. N. Meier, A. Schneider, M. P. Manns & M. Krüger. (2007) Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology 42:8, pages 1011-1017.
Read now
Read now
Articles from other publishers (34)
Chang Hu, Ravishankar K. Iyer, Brian D. Juran, Bryan M. McCauley, Elizabeth J. Atkinson, John E. Eaton, Ahmad H. Ali & Konstantinos N. Lazaridis. (2023) Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data. BMC Gastroenterology 23:1.
Crossref
Crossref
Giacomo MULINACCI, Laura CRISTOFERI, Andrea PALERMO, Martina LUCA, Alessio GERUSSI, Pietro INVERNIZZI & Marco CARBONE. (2023) Risk stratification in primary sclerosing cholangitis. Minerva Gastroenterology 69:1.
Crossref
Crossref
Natassia Tan, N. Ngu, T. Worland, T. Lee, T. Abrahams, K. Pandya, E. Freeman, N. Hannah, K. Gazelakis, R. G. Madden, K. D. Lynch, Z. Valaydon, S. Sood, A. Dev, S. Bell, A. Thompson, J. Ding, A. J. Nicoll, K. Liu, P. Gow, J. Lubel, W. Kemp, S. K. Roberts & A. Majeed. (2022) Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study. Hepatology International 16:5, pages 1094-1104.
Crossref
Crossref
Francesca Saffioti & Vasileios K Mavroeidis. (2021) Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis. World Journal of Gastrointestinal Oncology 13:10, pages 1336-1366.
Crossref
Crossref
Junmin Song, Yang Li, Christopher L. Bowlus, GuoXiang Yang, Patrick S. C. Leung & M. Eric Gershwin. (2019) Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review. Clinical Reviews in Allergy & Immunology 58:1, pages 134-149.
Crossref
Crossref
Laurent Ehrlich, April O’Brien, Chad Hall, Tori White, Lixian Chen, Nan Wu, Julie Venter, Marinda Scrushy, Muhammad Mubarak, Fanyin Meng, David Dostal, Chaodong Wu, Terry C. Lairmore, Gianfranco Alpini & Shannon Glaser. (2018) α7-nAChR Knockout Mice Decreases Biliary Hyperplasia and Liver Fibrosis in Cholestatic Bile Duct-Ligated Mice. Gene Expression 18:3, pages 197-207.
Crossref
Crossref
Yuenan Huang, Liuping You, Weimin Xie, Li Ning & Jinghe Lang. (2017) Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis. Oncotarget 8:59, pages 100570-100581.
Crossref
Crossref
Sebastian Torben Jendrek, Daniel Gotthardt, Thomas Nitzsche, Laila Widmann, Tobias Korf, Maike Anna Michaels, Karl-Heinz Weiss, Evaggelia Liaskou, Mette Vesterhus, Tom Hemming Karlsen, Swantje Mindorf, Peter Schemmer, Florian Bär, Bianca Teegen, Torsten Schröder, Marc Ehlers, Christoph Matthias Hammers, Lars Komorowski, Hendrik Lehnert, Klaus Fellermann, Stefanie Derer, Johannes Roksund Hov & Christian Sina. (2017) Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis. Gut 66:1, pages 137-144.
Crossref
Crossref
Montserrat Fraga, Nicolas Fournier, Ekaterina Safroneeva, Valérie Pittet, Sébastien Godat, Alex Straumann, Andreas Nydegger, Stephan R. Vavricka, Darius Moradpour & Alain M. Schoepfer. (2017) Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up. European Journal of Gastroenterology & Hepatology 29:1, pages 91-97.
Crossref
Crossref
Roger W. Chapman & Kate D. Williamson. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
531
547
.
Johanna Haapamäki, Andrea Tenca, Harri Sintonen, Nina Barner‐Rasmussen & Martti A. Färkkilä. (2015) Health‐related quality of life among patients with primary sclerosing cholangitis. Liver International 35:9, pages 2194-2201.
Crossref
Crossref
T.J. Weismüller, T.O. Lankisch & T. Voigtländer. (2014) Kolonkarzinom und Gallengangskarzinom bei primär sklerosierender CholangitisColon cancer and cholangiocarcinoma in primary sclerosing cholangitis. Der Gastroenterologe 10:1, pages 26-31.
Crossref
Crossref
Holger H. Lutz, Christian Trautwein & Jens J. W. Tischendorf. (2013) Primary Sclerosing Cholangitis. Deutsches Ärzteblatt international.
Crossref
Crossref
Nabeel S. Koro & Samer Alkaade. (2013) Role of Endoscopy in Primary Sclerosing Cholangitis. Current Gastroenterology Reports 15:12.
Crossref
Crossref
Kirsten Boonstra, Rinse K. Weersma, Karel J. van Erpecum, Erik A. Rauws, B.W. Marcel Spanier, Alexander C. Poen, Karin M. van Nieuwkerk, Joost P. Drenth, Ben J. Witteman, Hans A. Tuynman, Anton H. Naber, Paul J. Kingma, Henk R. van Buuren, Bart van Hoek, Frank P. Vleggaar, Nan van Geloven, Ulrich Beuers & Cyriel Y. Ponsioen. (2013) Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 58:6, pages 2045-2055.
Crossref
Crossref
Kendal Jensen, Syeda Afroze, Yoshiyuki Ueno, Kinan Rahal, Amber Frenzel, Melanie Sterling, Micheleine Guerrier, Damir Nizamutdinov, David E. Dostal, Fanyin Meng & Shannon S. Glaser. (2013) Chronic nicotine exposure stimulates biliary growth and fibrosis in normal rats. Digestive and Liver Disease 45:9, pages 754-761.
Crossref
Crossref
C.P. Strassburg. (2013) Indikationsstellung und Indikationen für eine LebertransplantationPatient selection and indications for liver transplantation. Der Chirurg 84:5, pages 363-371.
Crossref
Crossref
Maria Benito de Valle, Einar Björnsson & Björn Lindkvist. (2011) Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population‐based cohort. Liver International 32:3, pages 441-448.
Crossref
Crossref
John Halliday & Roger W. Chapman. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
579
600
.
C.P. Strassburg & M.P. Manns. (2011) Therapie der autoimmunen LebererkrankungenTreatment of autoimmune liver diseases. Der Internist 52:12, pages 1394-1406.
Crossref
Crossref
Preethi GK VENKATESH, Udayakumar NAVANEETHAN & Bo SHEN. (2011) Hepatobiliary disorders and complications of inflammatory bowel disease. Journal of Digestive Diseases 12:4, pages 245-256.
Crossref
Crossref
Simon Rushbrook & Roger W. Chapman. 2011. Sherlock's Diseases of the Liver and Biliary System. Sherlock's Diseases of the Liver and Biliary System
342
352
.
Nishchay Chandra, Susan N Cullen & Roger W Chapman. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
533
553
.
Udayakumar Navaneethan & Bo Shen. (2010) Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflammatory Bowel Diseases 16:9, pages 1598-1619.
Crossref
Crossref
Jens J. W. Tischendorf & Ramin Schirin-Sokhan. (2009) The importance of treating stenoses and infections. Nature Reviews Gastroenterology & Hepatology 6:12, pages 691-692.
Crossref
Crossref
C.P. Strassburg. (2009) Lebertransplantation im Zeitalter von MELDLiver transplantation at the age of MELD. Der Gastroenterologe 4:6, pages 501-512.
Crossref
Crossref
C.P. Strassburg & M.P. Manns. (2009) LebertransplantationLiver transplantation: indications and results. Der Internist 50:5, pages 550-560.
Crossref
Crossref
T.J. Weismüller & J. Wedemeyer. (2009) Primär sklerosierende CholangitisPrimary sclerosing cholangitis. Der Gastroenterologe 4:2, pages 115-123.
Crossref
Crossref
T.M. Antonini & D. Samuel. (2009) Indications et résultats de la greffe hépatique (hors carcinome hépatocellulaire et hépatite fulminante). Gastroentérologie Clinique et Biologique 33:1, pages 44-50.
Crossref
Crossref
Jens J. W. Tischendorf, Andreas Geier & Christian Trautwein. (2008) Current diagnosis and management of primary sclerosing cholangitis. Liver Transplantation 14:6, pages 735-746.
Crossref
Crossref
James RL Maggs & Roger W Chapman. (2008) An update on primary sclerosing cholangitis. Current Opinion in Gastroenterology 24:3, pages 377-383.
Crossref
Crossref
Tobias J. Weismüller, Jochen Wedemeyer, Stefan Kubicka, Christian P. Strassburg & Michael P. Manns. (2008) The challenges in primary sclerosing cholangitis – Aetiopathogenesis, autoimmunity, management and malignancy. Journal of Hepatology 48, pages S38-S57.
Crossref
Crossref
James RL Maggs & Roger W Chapman. (2007) Sclerosing cholangitis. Current Opinion in Gastroenterology 23:3, pages 310-316.
Crossref
Crossref
Christian P. Strassburg, Arndt Vogel & Michael P. Manns. 2007. Medizinische Therapie 2007 | 2008. Medizinische Therapie 2007 | 2008
910
915
.